{
  "metadata": {
    "kernelspec": {
      "language": "python",
      "display_name": "Python 3",
      "name": "python3"
    },
    "language_info": {
      "name": "python",
      "version": "3.11.11",
      "mimetype": "text/x-python",
      "codemirror_mode": {
        "name": "ipython",
        "version": 3
      },
      "pygments_lexer": "ipython3",
      "nbconvert_exporter": "python",
      "file_extension": ".py"
    },
    "kaggle": {
      "accelerator": "nvidiaTeslaT4",
      "dataSources": [],
      "dockerImageVersionId": 31011,
      "isInternetEnabled": true,
      "language": "python",
      "sourceType": "notebook",
      "isGpuEnabled": true
    },
    "colab": {
      "provenance": []
    }
  },
  "nbformat_minor": 0,
  "nbformat": 4,
  "cells": [
    {
      "cell_type": "code",
      "source": [
        "from huggingface_hub import login\n",
        "login(token=\"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\")"
      ],
      "metadata": {
        "_uuid": "8f2839f25d086af736a60e9eeb907d3b93b6e0e5",
        "_cell_guid": "b1076dfc-b9ad-4769-8c92-a6c4dae69d19",
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T15:33:56.768094Z",
          "iopub.execute_input": "2025-05-20T15:33:56.768751Z",
          "iopub.status.idle": "2025-05-20T15:33:56.888440Z",
          "shell.execute_reply.started": "2025-05-20T15:33:56.768726Z",
          "shell.execute_reply": "2025-05-20T15:33:56.887678Z"
        },
        "id": "avg8H_M9JwuY"
      },
      "outputs": [],
      "execution_count": null
    },
    {
      "cell_type": "code",
      "source": [
        "!pip install virtualenv\n",
        "!virtualenv qa_venv"
      ],
      "metadata": {
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T15:33:58.574628Z",
          "iopub.execute_input": "2025-05-20T15:33:58.574927Z",
          "iopub.status.idle": "2025-05-20T15:34:08.156621Z",
          "shell.execute_reply.started": "2025-05-20T15:33:58.574906Z",
          "shell.execute_reply": "2025-05-20T15:34:08.155682Z"
        },
        "collapsed": true,
        "jupyter": {
          "outputs_hidden": true
        },
        "id": "EdsCRfZGJwug",
        "outputId": "f1b0fb84-98c4-4f01-d4ee-bb8bbf5a922a"
      },
      "outputs": [
        {
          "name": "stdout",
          "text": "Collecting virtualenv\n  Downloading virtualenv-20.31.2-py3-none-any.whl.metadata (4.5 kB)\nCollecting distlib<1,>=0.3.7 (from virtualenv)\n  Downloading distlib-0.3.9-py2.py3-none-any.whl.metadata (5.2 kB)\nRequirement already satisfied: filelock<4,>=3.12.2 in /usr/local/lib/python3.11/dist-packages (from virtualenv) (3.18.0)\nRequirement already satisfied: platformdirs<5,>=3.9.1 in /usr/local/lib/python3.11/dist-packages (from virtualenv) (4.3.7)\nDownloading virtualenv-20.31.2-py3-none-any.whl (6.1 MB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m6.1/6.1 MB\u001b[0m \u001b[31m46.3 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m00:01\u001b[0m00:01\u001b[0m\n\u001b[?25hDownloading distlib-0.3.9-py2.py3-none-any.whl (468 kB)\n\u001b[2K   \u001b[90m━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━\u001b[0m \u001b[32m469.0/469.0 kB\u001b[0m \u001b[31m18.5 MB/s\u001b[0m eta \u001b[36m0:00:00\u001b[0m\n\u001b[?25hInstalling collected packages: distlib, virtualenv\nSuccessfully installed distlib-0.3.9 virtualenv-20.31.2\ncreated virtual environment CPython3.11.11.final.0-64 in 589ms\n  creator CPython3Posix(dest=/kaggle/working/qa_venv, clear=False, no_vcs_ignore=False, global=False)\n  seeder FromAppData(download=False, pip=bundle, setuptools=bundle, via=copy, app_data_dir=/root/.local/share/virtualenv)\n    added seed packages: pip==25.1.1, setuptools==80.3.1\n  activators BashActivator,CShellActivator,FishActivator,NushellActivator,PowerShellActivator,PythonActivator\n",
          "output_type": "stream"
        }
      ],
      "execution_count": null
    },
    {
      "cell_type": "code",
      "source": [
        "import sys\n",
        "print(sys.version)"
      ],
      "metadata": {
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T15:34:08.158335Z",
          "iopub.execute_input": "2025-05-20T15:34:08.158635Z",
          "iopub.status.idle": "2025-05-20T15:34:08.163205Z",
          "shell.execute_reply.started": "2025-05-20T15:34:08.158596Z",
          "shell.execute_reply": "2025-05-20T15:34:08.162566Z"
        },
        "id": "3mHUZ8T5Jwui",
        "outputId": "da139fe0-876f-4d36-cab2-7dbdb1f1ee99"
      },
      "outputs": [
        {
          "name": "stdout",
          "text": "3.11.11 (main, Dec  4 2024, 08:55:07) [GCC 11.4.0]\n",
          "output_type": "stream"
        }
      ],
      "execution_count": null
    },
    {
      "cell_type": "code",
      "source": [
        "import os\n",
        "venv_path = os.path.expanduser('/kaggle/working/qa_venv/bin')\n",
        "os.environ['PATH'] = f\"{venv_path}:{os.environ['PATH']}\"\n",
        "sys.path.insert(0, os.path.expanduser('/kaggle/working/qa_venv/lib/python3.11/site-packages'))"
      ],
      "metadata": {
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T15:34:08.163975Z",
          "iopub.execute_input": "2025-05-20T15:34:08.164248Z",
          "iopub.status.idle": "2025-05-20T15:34:08.231277Z",
          "shell.execute_reply.started": "2025-05-20T15:34:08.164223Z",
          "shell.execute_reply": "2025-05-20T15:34:08.230405Z"
        },
        "id": "CYQJB5jzJwuj"
      },
      "outputs": [],
      "execution_count": null
    },
    {
      "cell_type": "code",
      "source": [
        "from datasets import load_dataset\n",
        "\n",
        "# Load the dataset\n",
        "convfinqa_dataset = load_dataset(\"ChanceFocus/flare-convfinqa\", split=\"test\")\n",
        "\n",
        "# Display some basic information about the dataset\n",
        "print(\"Dataset Features:\")\n",
        "print(convfinqa_dataset.features)\n",
        "\n",
        "print(\"\\nExamples from the Dataset:\")\n",
        "print(convfinqa_dataset[:5])  # Display the first 5 examples\n",
        "\n",
        "# Analyze the structure and contents\n",
        "print(\"\\nNumber of Entries in the Dataset:\", len(convfinqa_dataset))\n",
        "\n",
        "# Example of accessing specific fields\n",
        "for example in convfinqa_dataset[:5]:\n",
        "    print(f\"ID: {example['id']}\")\n",
        "    print(f\"Query: {example['query']}\")\n",
        "    print(f\"Answer: {example['answer']}\")\n",
        "    print(f\"Turn: {example['turn']}\")\n",
        "    print(f\"Dialogue ID: {example['dialogue_id']}\")\n",
        "    print(\"-\" * 50)"
      ],
      "metadata": {
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T10:05:29.120732Z",
          "iopub.execute_input": "2025-05-20T10:05:29.121018Z",
          "iopub.status.idle": "2025-05-20T10:05:30.829870Z",
          "shell.execute_reply.started": "2025-05-20T10:05:29.120998Z",
          "shell.execute_reply": "2025-05-20T10:05:30.828937Z"
        },
        "jupyter": {
          "outputs_hidden": true
        },
        "collapsed": true,
        "id": "mh3rYgIxJwuk",
        "outputId": "d3b25e6e-55c1-463c-fc18-0c1154b696d6"
      },
      "outputs": [
        {
          "name": "stdout",
          "text": "Dataset Features:\n{'id': Value(dtype='string', id=None), 'query': Value(dtype='string', id=None), 'answer': Value(dtype='string', id=None), 'turn': Value(dtype='int64', id=None), 'dialogue_id': Value(dtype='int64', id=None)}\n\nExamples from the Dataset:\n{'id': ['convfinqa0', 'convfinqa1', 'convfinqa2', 'convfinqa3', 'convfinqa4'], 'query': [\"In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\\nConversations: \\nQuestion: what was the weighted average exercise price per share in 2007?\\nAnswer:\", \"In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\\nConversations: \\nq0: what was the weighted average exercise price per share in 2007? {answer0}\\nQuestion: and what was it in 2005?\\nAnswer:\", \"In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\\nConversations: \\nq0: what was the weighted average exercise price per share in 2007? {answer0}\\nq1: and what was it in 2005? {answer1}\\nQuestion: what was, then, the change over the years?\\nAnswer:\", \"In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\\nConversations: \\nq0: what was the weighted average exercise price per share in 2007? {answer0}\\nq1: and what was it in 2005? {answer1}\\nq2: what was, then, the change over the years? {answer2}\\nQuestion: what was the weighted average exercise price per share in 2005?\\nAnswer:\", \"In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\\nConversations: \\nq0: what was the weighted average exercise price per share in 2007? {answer0}\\nq1: and what was it in 2005? {answer1}\\nq2: what was, then, the change over the years? {answer2}\\nq3: what was the weighted average exercise price per share in 2005? {answer3}\\nQuestion: and how much does that change represent in relation to this 2005 weighted average exercise price?\\nAnswer:\"], 'answer': ['60.94', '25.14', '35.8', '25.14', '1.42403'], 'turn': [0, 1, 2, 3, 4], 'dialogue_id': [0, 0, 0, 0, 0]}\n\nNumber of Entries in the Dataset: 1490\n",
          "output_type": "stream"
        },
        {
          "traceback": [
            "\u001b[0;31m---------------------------------------------------------------------------\u001b[0m",
            "\u001b[0;31mTypeError\u001b[0m                                 Traceback (most recent call last)",
            "\u001b[0;32m/tmp/ipykernel_31/3097386562.py\u001b[0m in \u001b[0;36m<cell line: 0>\u001b[0;34m()\u001b[0m\n\u001b[1;32m     16\u001b[0m \u001b[0;31m# Example of accessing specific fields\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     17\u001b[0m \u001b[0;32mfor\u001b[0m \u001b[0mexample\u001b[0m \u001b[0;32min\u001b[0m \u001b[0mconvfinqa_dataset\u001b[0m\u001b[0;34m[\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;36m5\u001b[0m\u001b[0;34m]\u001b[0m\u001b[0;34m:\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0;32m---> 18\u001b[0;31m     \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34mf\"ID: {example['id']}\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[0m\u001b[1;32m     19\u001b[0m     \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34mf\"Query: {example['query']}\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n\u001b[1;32m     20\u001b[0m     \u001b[0mprint\u001b[0m\u001b[0;34m(\u001b[0m\u001b[0;34mf\"Answer: {example['answer']}\"\u001b[0m\u001b[0;34m)\u001b[0m\u001b[0;34m\u001b[0m\u001b[0;34m\u001b[0m\u001b[0m\n",
            "\u001b[0;31mTypeError\u001b[0m: string indices must be integers, not 'str'"
          ],
          "ename": "TypeError",
          "evalue": "string indices must be integers, not 'str'",
          "output_type": "error"
        }
      ],
      "execution_count": null
    },
    {
      "cell_type": "code",
      "source": [
        "from transformers import LlamaTokenizer, LlamaForCausalLM, pipeline\n",
        "import torch\n",
        "\n",
        "# Load tokenizer and model\n",
        "model_name = \"ChanceFocus/finma-7b-full\"\n",
        "tokenizer = LlamaTokenizer.from_pretrained(model_name, legacy=False)\n",
        "model = LlamaForCausalLM.from_pretrained(model_name,device_map=\"auto\",torch_dtype=torch.float16)\n",
        "\n",
        "# Set pad_token_id to avoid generation errors\n",
        "model.generation_config.pad_token_id = tokenizer.pad_token_id or tokenizer.eos_token_id\n",
        "model.eval()\n",
        "\n",
        "# Create a text-generation pipeline\n",
        "finma_generator = pipeline(\"text-generation\", model=model,tokenizer=tokenizer)"
      ],
      "metadata": {
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T15:34:11.168012Z",
          "iopub.execute_input": "2025-05-20T15:34:11.168361Z",
          "iopub.status.idle": "2025-05-20T15:41:16.135077Z",
          "shell.execute_reply.started": "2025-05-20T15:34:11.168338Z",
          "shell.execute_reply": "2025-05-20T15:41:16.134409Z"
        },
        "colab": {
          "referenced_widgets": [
            "b0ec07a694ca40789835f1cb27974d1d",
            "2a14eaeb252c47a0a22ee2ecf03ced97",
            "83955f6d569c42808e32627ae3eae90f",
            "e5c252daf82843329decf9275662cec9",
            "726386dc6c9340369064ba6a8bd605d9",
            "d3941401d88646eabf4c2fba85bcff61",
            "3a5fefc1b8c94da2874803dcce9b8674",
            "980d96783bf344cf8311a5eda4ec78c2"
          ]
        },
        "id": "S2dwneI3Jwum",
        "outputId": "db51897a-fb5d-467f-91c2-61f5b9821bb9"
      },
      "outputs": [
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "tokenizer_config.json:   0%|          | 0.00/812 [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "b0ec07a694ca40789835f1cb27974d1d"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "tokenizer.model:   0%|          | 0.00/500k [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "2a14eaeb252c47a0a22ee2ecf03ced97"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "added_tokens.json:   0%|          | 0.00/21.0 [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "83955f6d569c42808e32627ae3eae90f"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "special_tokens_map.json:   0%|          | 0.00/96.0 [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "e5c252daf82843329decf9275662cec9"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "config.json:   0%|          | 0.00/567 [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "726386dc6c9340369064ba6a8bd605d9"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "pytorch_model.bin:   0%|          | 0.00/27.0G [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "d3941401d88646eabf4c2fba85bcff61"
            }
          },
          "metadata": {}
        },
        {
          "name": "stderr",
          "text": "/usr/local/lib/python3.11/dist-packages/transformers/generation/configuration_utils.py:609: UserWarning: `pad_token_id` should be positive but got -1. This will cause errors when batch generating, if there is padding. Please set `pad_token_id` explicitly as `model.generation_config.pad_token_id=PAD_TOKEN_ID` to avoid errors in generation\n  warnings.warn(\n",
          "output_type": "stream"
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "model.safetensors:   0%|          | 0.00/27.0G [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "3a5fefc1b8c94da2874803dcce9b8674"
            }
          },
          "metadata": {}
        },
        {
          "output_type": "display_data",
          "data": {
            "text/plain": "generation_config.json:   0%|          | 0.00/132 [00:00<?, ?B/s]",
            "application/vnd.jupyter.widget-view+json": {
              "version_major": 2,
              "version_minor": 0,
              "model_id": "980d96783bf344cf8311a5eda4ec78c2"
            }
          },
          "metadata": {}
        },
        {
          "name": "stderr",
          "text": "Device set to use cuda:0\n",
          "output_type": "stream"
        }
      ],
      "execution_count": null
    },
    {
      "cell_type": "markdown",
      "source": [
        "# Convfiqa with zero-shot"
      ],
      "metadata": {
        "id": "BL6GYxIGJwun"
      }
    },
    {
      "cell_type": "code",
      "source": [
        "# On convfinqa\n",
        "from tqdm import tqdm\n",
        "import numpy as np\n",
        "\n",
        "# Load dataset\n",
        "convfinqa_dataset = load_dataset(\"ChanceFocus/flare-convfinqa\", split=\"test\")\n",
        "\n",
        "def normalize_answer(s):\n",
        "    \"\"\"Lower text and remove extra whitespaces and punctuation.\"\"\"\n",
        "    import re\n",
        "    return ' '.join(re.sub(r'[^a-zA-Z0-9\\.]', ' ', str(s).lower()).split())\n",
        "\n",
        "def compute_exact(a_pred, a_true):\n",
        "    return normalize_answer(a_pred) == normalize_answer(a_true)\n",
        "\n",
        "def compute_f1(a_pred, a_true):\n",
        "    pred_tokens = normalize_answer(a_pred).split()\n",
        "    true_tokens = normalize_answer(a_true).split()\n",
        "    common = set(pred_tokens) & set(true_tokens)\n",
        "    if not common:\n",
        "        return 0.0\n",
        "    prec = len(common) / max(1, len(pred_tokens))\n",
        "    rec = len(common) / max(1, len(true_tokens))\n",
        "    return 2 * prec * rec / (prec + rec)\n",
        "\n",
        "def generate_answer(query, context, max_new_tokens=32):\n",
        "    prompt = (\n",
        "        f\"Question: {query}\\n\"\n",
        "        f\"Context: {context}\\n\"\n",
        "        \"Answer with only a number:\\nAnswer:\")\n",
        "    inputs = tokenizer(prompt, return_tensors=\"pt\").to(model.device)\n",
        "    with torch.no_grad():\n",
        "        outputs = model.generate(\n",
        "            **inputs,\n",
        "            max_new_tokens=max_new_tokens,\n",
        "            pad_token_id=tokenizer.eos_token_id)\n",
        "\n",
        "    # Only extract the portion after 'Answer:'\n",
        "    generated = tokenizer.decode(outputs[0], skip_special_tokens=True)\n",
        "    if 'Answer:' in generated:\n",
        "        return generated.split('Answer:')[-1].strip()\n",
        "    return generated.strip()\n",
        "\n",
        "results = []\n",
        "for example in tqdm(convfinqa_dataset):\n",
        "    query = example[\"query\"]\n",
        "    context = example.get(\"context\", \"\")\n",
        "    gold = str(example[\"answer\"])\n",
        "    pred = generate_answer(query, context)\n",
        "    results.append({\n",
        "        \"query\": query,\n",
        "        \"context\": context,\n",
        "        \"gold\": gold,\n",
        "        \"pred\": pred,\n",
        "        \"exact\": compute_exact(pred, gold),\n",
        "        \"f1\": compute_f1(pred, gold)\n",
        "    })\n",
        "\n",
        "exact_scores = [item[\"exact\"] for item in results]\n",
        "f1_scores = [item[\"f1\"] for item in results]\n",
        "print(f\"Exact Match: {np.mean(exact_scores):.4f}\")\n",
        "print(f\"F1 Score: {np.mean(f1_scores):.4f}\")\n",
        "\n",
        "# Show a few predictions\n",
        "for item in results[:10]:\n",
        "    print(\"\\nQuestion:\", item[\"query\"])\n",
        "    print(\"Gold Answer:\", item[\"gold\"])\n",
        "    print(\"Model Answer:\", item[\"pred\"])\n",
        "    print(\"Exact:\", item[\"exact\"], \"F1:\", item[\"f1\"])"
      ],
      "metadata": {
        "trusted": true,
        "execution": {
          "iopub.status.busy": "2025-05-20T10:50:35.709381Z",
          "iopub.execute_input": "2025-05-20T10:50:35.709985Z",
          "iopub.status.idle": "2025-05-20T11:30:35.729964Z",
          "shell.execute_reply.started": "2025-05-20T10:50:35.709958Z",
          "shell.execute_reply": "2025-05-20T11:30:35.729208Z"
        },
        "jupyter": {
          "outputs_hidden": true
        },
        "id": "5QOuoC2eJwuq",
        "outputId": "f62e1d17-98a2-4ab7-cfd2-29769263ee71"
      },
      "outputs": [
        {
          "name": "stderr",
          "text": "100%|██████████| 1490/1490 [39:59<00:00,  1.61s/it]",
          "output_type": "stream"
        },
        {
          "name": "stdout",
          "text": "Exact Match: 0.3644\nF1 Score: 0.3644\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\nConversations: \nQuestion: what was the weighted average exercise price per share in 2007?\nAnswer:\nGold Answer: 60.94\nModel Answer: 60.94\nExact: True F1: 1.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\nConversations: \nq0: what was the weighted average exercise price per share in 2007? {answer0}\nQuestion: and what was it in 2005?\nAnswer:\nGold Answer: 25.14\nModel Answer: 25.14\nExact: True F1: 1.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\nConversations: \nq0: what was the weighted average exercise price per share in 2007? {answer0}\nq1: and what was it in 2005? {answer1}\nQuestion: what was, then, the change over the years?\nAnswer:\nGold Answer: 35.8\nModel Answer: 33.79\nExact: False F1: 0.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\nConversations: \nq0: what was the weighted average exercise price per share in 2007? {answer0}\nq1: and what was it in 2005? {answer1}\nq2: what was, then, the change over the years? {answer2}\nQuestion: what was the weighted average exercise price per share in 2005?\nAnswer:\nGold Answer: 25.14\nModel Answer: 25.14\nExact: True F1: 1.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: stock-based awards under the plan stock options 2013 marathon grants stock options under the 2007 plan and previously granted options under the 2003 plan . marathon 2019s stock options represent the right to purchase shares of common stock at the fair market value of the common stock on the date of grant . through 2004 , certain stock options were granted under the 2003 plan with a tandem stock appreciation right , which allows the recipient to instead elect to receive cash and/or common stock equal to the excess of the fair market value of shares of common stock , as determined in accordance with the 2003 plan , over the option price of the shares . in general , stock options granted under the 2007 plan and the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock appreciation rights 2013 prior to 2005 , marathon granted sars under the 2003 plan . no stock appreciation rights have been granted under the 2007 plan . similar to stock options , stock appreciation rights represent the right to receive a payment equal to the excess of the fair market value of shares of common stock on the date the right is exercised over the grant price . under the 2003 plan , certain sars were granted as stock-settled sars and others were granted in tandem with stock options . in general , sars granted under the 2003 plan vest ratably over a three-year period and have a maximum term of ten years from the date they are granted . stock-based performance awards 2013 prior to 2005 , marathon granted stock-based performance awards under the 2003 plan . no stock-based performance awards have been granted under the 2007 plan . beginning in 2005 , marathon discontinued granting stock-based performance awards and instead now grants cash-settled performance units to officers . all stock-based performance awards granted under the 2003 plan have either vested or been forfeited . as a result , there are no outstanding stock-based performance awards . restricted stock 2013 marathon grants restricted stock and restricted stock units under the 2007 plan and previously granted such awards under the 2003 plan . in 2005 , the compensation committee began granting time-based restricted stock to certain u.s.-based officers of marathon and its consolidated subsidiaries as part of their annual long-term incentive package . the restricted stock awards to officers vest three years from the date of grant , contingent on the recipient 2019s continued employment . marathon also grants restricted stock to certain non-officer employees and restricted stock units to certain international employees ( 201crestricted stock awards 201d ) , based on their performance within certain guidelines and for retention purposes . the restricted stock awards to non-officers generally vest in one-third increments over a three-year period , contingent on the recipient 2019s continued employment . prior to vesting , all restricted stock recipients have the right to vote such stock and receive dividends thereon . the non-vested shares are not transferable and are held by marathon 2019s transfer agent . common stock units 2013 marathon maintains an equity compensation program for its non-employee directors under the 2007 plan and previously maintained such a program under the 2003 plan . all non-employee directors other than the chairman receive annual grants of common stock units , and they are required to hold those units until they leave the board of directors . when dividends are paid on marathon common stock , directors receive dividend equivalents in the form of additional common stock units . stock-based compensation expense 2013 total employee stock-based compensation expense was $ 80 million , $ 83 million and $ 111 million in 2007 , 2006 and 2005 . the total related income tax benefits were $ 29 million , $ 31 million and $ 39 million . in 2007 and 2006 , cash received upon exercise of stock option awards was $ 27 million and $ 50 million . tax benefits realized for deductions during 2007 and 2006 that were in excess of the stock-based compensation expense recorded for options exercised and other stock-based awards vested during the period totaled $ 30 million and $ 36 million . cash settlements of stock option awards totaled $ 1 million and $ 3 million in 2007 and 2006 . stock option awards granted 2013 during 2007 , 2006 and 2005 , marathon granted stock option awards to both officer and non-officer employees . the weighted average grant date fair value of these awards was based on the following black-scholes assumptions: . <table class='wikitable'><tr><td>1</td><td></td><td>2007</td><td>2006</td><td>2005</td></tr><tr><td>2</td><td>weighted average exercise price per share</td><td>$ 60.94</td><td>$ 37.84</td><td>$ 25.14</td></tr><tr><td>3</td><td>expected annual dividends per share</td><td>$ 0.96</td><td>$ 0.80</td><td>$ 0.66</td></tr><tr><td>4</td><td>expected life in years</td><td>5.0</td><td>5.1</td><td>5.5</td></tr><tr><td>5</td><td>expected volatility</td><td>27% ( 27 % )</td><td>28% ( 28 % )</td><td>28% ( 28 % )</td></tr><tr><td>6</td><td>risk-free interest rate</td><td>4.1% ( 4.1 % )</td><td>5.0% ( 5.0 % )</td><td>3.8% ( 3.8 % )</td></tr><tr><td>7</td><td>weighted average grant date fair value of stock option awards granted</td><td>$ 17.24</td><td>$ 10.19</td><td>$ 6.15</td></tr></table> .\nConversations: \nq0: what was the weighted average exercise price per share in 2007? {answer0}\nq1: and what was it in 2005? {answer1}\nq2: what was, then, the change over the years? {answer2}\nq3: what was the weighted average exercise price per share in 2005? {answer3}\nQuestion: and how much does that change represent in relation to this 2005 weighted average exercise price?\nAnswer:\nGold Answer: 1.42403\nModel Answer: 0.44853\nExact: False F1: 0.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: as of december 31 , 2017 , the company had gross state income tax credit carry-forwards of approximately $ 20 million , which expire from 2018 through 2020 . a deferred tax asset of approximately $ 16 million ( net of federal benefit ) has been established related to these state income tax credit carry-forwards , with a valuation allowance of $ 7 million against such deferred tax asset as of december 31 , 2017 . the company had a gross state net operating loss carry-forward of $ 39 million , which expires in 2027 . a deferred tax asset of approximately $ 3 million ( net of federal benefit ) has been established for the net operating loss carry-forward , with a full valuation allowance as of december 31 , 2017 . other state and foreign net operating loss carry-forwards are separately and cumulatively immaterial to the company 2019s deferred tax balances and expire between 2026 and 2036 . 14 . debt long-term debt consisted of the following: . <table class='wikitable'><tr><td>1</td><td>( $ in millions )</td><td>december 31 2017</td><td>december 31 2016</td></tr><tr><td>2</td><td>senior notes due december 15 2021 5.000% ( 5.000 % )</td><td>2014</td><td>600</td></tr><tr><td>3</td><td>senior notes due november 15 2025 5.000% ( 5.000 % )</td><td>600</td><td>600</td></tr><tr><td>4</td><td>senior notes due december 1 2027 3.483% ( 3.483 % )</td><td>600</td><td>2014</td></tr><tr><td>5</td><td>mississippi economic development revenue bonds due may 1 2024 7.81% ( 7.81 % )</td><td>84</td><td>84</td></tr><tr><td>6</td><td>gulf opportunity zone industrial development revenue bonds due december 1 2028 4.55% ( 4.55 % )</td><td>21</td><td>21</td></tr><tr><td>7</td><td>less unamortized debt issuance costs</td><td>-26 ( 26 )</td><td>-27 ( 27 )</td></tr><tr><td>8</td><td>total long-term debt</td><td>1279</td><td>1278</td></tr></table> credit facility - in november 2017 , the company terminated its second amended and restated credit agreement and entered into a new credit agreement ( the \"credit facility\" ) with third-party lenders . the credit facility includes a revolving credit facility of $ 1250 million , which may be drawn upon during a period of five years from november 22 , 2017 . the revolving credit facility includes a letter of credit subfacility of $ 500 million . the revolving credit facility has a variable interest rate on outstanding borrowings based on the london interbank offered rate ( \"libor\" ) plus a spread based upon the company's credit rating , which may vary between 1.125% ( 1.125 % ) and 1.500% ( 1.500 % ) . the revolving credit facility also has a commitment fee rate on the unutilized balance based on the company 2019s leverage ratio . the commitment fee rate as of december 31 , 2017 was 0.25% ( 0.25 % ) and may vary between 0.20% ( 0.20 % ) and 0.30% ( 0.30 % ) . the credit facility contains customary affirmative and negative covenants , as well as a financial covenant based on a maximum total leverage ratio . each of the company's existing and future material wholly owned domestic subsidiaries , except those that are specifically designated as unrestricted subsidiaries , are and will be guarantors under the credit facility . in july 2015 , the company used cash on hand to repay all amounts outstanding under a prior credit facility , including $ 345 million in principal amount of outstanding term loans . as of december 31 , 2017 , $ 15 million in letters of credit were issued but undrawn , and the remaining $ 1235 million of the revolving credit facility was unutilized . the company had unamortized debt issuance costs associated with its credit facilities of $ 11 million and $ 8 million as of december 31 , 2017 and 2016 , respectively . senior notes - in december 2017 , the company issued $ 600 million aggregate principal amount of unregistered 3.483% ( 3.483 % ) senior notes with registration rights due december 2027 , the net proceeds of which were used to repurchase the company's 5.000% ( 5.000 % ) senior notes due in 2021 in connection with the 2017 redemption described below . in november 2015 , the company issued $ 600 million aggregate principal amount of unregistered 5.000% ( 5.000 % ) senior notes due november 2025 , the net proceeds of which were used to repurchase the company's 7.125% ( 7.125 % ) senior notes due in 2021 in connection with the 2015 tender offer and redemption described below . interest on the company's senior notes is payable semi-annually . the terms of the 5.000% ( 5.000 % ) and 3.483% ( 3.483 % ) senior notes limit the company 2019s ability and the ability of certain of its subsidiaries to create liens , enter into sale and leaseback transactions , sell assets , and effect consolidations or mergers . the company had unamortized debt issuance costs associated with the senior notes of $ 15 million and $ 19 million as of december 31 , 2017 and 2016 , respectively. .\nConversations: \nQuestion: what was the change in the unamortized debt issuance costs associated with the senior notes between 2016 and 2017?\nAnswer:\nGold Answer: -4.0\nModel Answer: -4.0\nExact: True F1: 1.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: as of december 31 , 2017 , the company had gross state income tax credit carry-forwards of approximately $ 20 million , which expire from 2018 through 2020 . a deferred tax asset of approximately $ 16 million ( net of federal benefit ) has been established related to these state income tax credit carry-forwards , with a valuation allowance of $ 7 million against such deferred tax asset as of december 31 , 2017 . the company had a gross state net operating loss carry-forward of $ 39 million , which expires in 2027 . a deferred tax asset of approximately $ 3 million ( net of federal benefit ) has been established for the net operating loss carry-forward , with a full valuation allowance as of december 31 , 2017 . other state and foreign net operating loss carry-forwards are separately and cumulatively immaterial to the company 2019s deferred tax balances and expire between 2026 and 2036 . 14 . debt long-term debt consisted of the following: . <table class='wikitable'><tr><td>1</td><td>( $ in millions )</td><td>december 31 2017</td><td>december 31 2016</td></tr><tr><td>2</td><td>senior notes due december 15 2021 5.000% ( 5.000 % )</td><td>2014</td><td>600</td></tr><tr><td>3</td><td>senior notes due november 15 2025 5.000% ( 5.000 % )</td><td>600</td><td>600</td></tr><tr><td>4</td><td>senior notes due december 1 2027 3.483% ( 3.483 % )</td><td>600</td><td>2014</td></tr><tr><td>5</td><td>mississippi economic development revenue bonds due may 1 2024 7.81% ( 7.81 % )</td><td>84</td><td>84</td></tr><tr><td>6</td><td>gulf opportunity zone industrial development revenue bonds due december 1 2028 4.55% ( 4.55 % )</td><td>21</td><td>21</td></tr><tr><td>7</td><td>less unamortized debt issuance costs</td><td>-26 ( 26 )</td><td>-27 ( 27 )</td></tr><tr><td>8</td><td>total long-term debt</td><td>1279</td><td>1278</td></tr></table> credit facility - in november 2017 , the company terminated its second amended and restated credit agreement and entered into a new credit agreement ( the \"credit facility\" ) with third-party lenders . the credit facility includes a revolving credit facility of $ 1250 million , which may be drawn upon during a period of five years from november 22 , 2017 . the revolving credit facility includes a letter of credit subfacility of $ 500 million . the revolving credit facility has a variable interest rate on outstanding borrowings based on the london interbank offered rate ( \"libor\" ) plus a spread based upon the company's credit rating , which may vary between 1.125% ( 1.125 % ) and 1.500% ( 1.500 % ) . the revolving credit facility also has a commitment fee rate on the unutilized balance based on the company 2019s leverage ratio . the commitment fee rate as of december 31 , 2017 was 0.25% ( 0.25 % ) and may vary between 0.20% ( 0.20 % ) and 0.30% ( 0.30 % ) . the credit facility contains customary affirmative and negative covenants , as well as a financial covenant based on a maximum total leverage ratio . each of the company's existing and future material wholly owned domestic subsidiaries , except those that are specifically designated as unrestricted subsidiaries , are and will be guarantors under the credit facility . in july 2015 , the company used cash on hand to repay all amounts outstanding under a prior credit facility , including $ 345 million in principal amount of outstanding term loans . as of december 31 , 2017 , $ 15 million in letters of credit were issued but undrawn , and the remaining $ 1235 million of the revolving credit facility was unutilized . the company had unamortized debt issuance costs associated with its credit facilities of $ 11 million and $ 8 million as of december 31 , 2017 and 2016 , respectively . senior notes - in december 2017 , the company issued $ 600 million aggregate principal amount of unregistered 3.483% ( 3.483 % ) senior notes with registration rights due december 2027 , the net proceeds of which were used to repurchase the company's 5.000% ( 5.000 % ) senior notes due in 2021 in connection with the 2017 redemption described below . in november 2015 , the company issued $ 600 million aggregate principal amount of unregistered 5.000% ( 5.000 % ) senior notes due november 2025 , the net proceeds of which were used to repurchase the company's 7.125% ( 7.125 % ) senior notes due in 2021 in connection with the 2015 tender offer and redemption described below . interest on the company's senior notes is payable semi-annually . the terms of the 5.000% ( 5.000 % ) and 3.483% ( 3.483 % ) senior notes limit the company 2019s ability and the ability of certain of its subsidiaries to create liens , enter into sale and leaseback transactions , sell assets , and effect consolidations or mergers . the company had unamortized debt issuance costs associated with the senior notes of $ 15 million and $ 19 million as of december 31 , 2017 and 2016 , respectively. .\nConversations: \nq0: what was the change in the unamortized debt issuance costs associated with the senior notes between 2016 and 2017? {answer0}\nQuestion: so what was the percentage change during this time?\nAnswer:\nGold Answer: -0.21053\nModel Answer: 0.28571\nExact: False F1: 0.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: as of december 31 , 2017 , the company had gross state income tax credit carry-forwards of approximately $ 20 million , which expire from 2018 through 2020 . a deferred tax asset of approximately $ 16 million ( net of federal benefit ) has been established related to these state income tax credit carry-forwards , with a valuation allowance of $ 7 million against such deferred tax asset as of december 31 , 2017 . the company had a gross state net operating loss carry-forward of $ 39 million , which expires in 2027 . a deferred tax asset of approximately $ 3 million ( net of federal benefit ) has been established for the net operating loss carry-forward , with a full valuation allowance as of december 31 , 2017 . other state and foreign net operating loss carry-forwards are separately and cumulatively immaterial to the company 2019s deferred tax balances and expire between 2026 and 2036 . 14 . debt long-term debt consisted of the following: . <table class='wikitable'><tr><td>1</td><td>( $ in millions )</td><td>december 31 2017</td><td>december 31 2016</td></tr><tr><td>2</td><td>senior notes due december 15 2021 5.000% ( 5.000 % )</td><td>2014</td><td>600</td></tr><tr><td>3</td><td>senior notes due november 15 2025 5.000% ( 5.000 % )</td><td>600</td><td>600</td></tr><tr><td>4</td><td>senior notes due december 1 2027 3.483% ( 3.483 % )</td><td>600</td><td>2014</td></tr><tr><td>5</td><td>mississippi economic development revenue bonds due may 1 2024 7.81% ( 7.81 % )</td><td>84</td><td>84</td></tr><tr><td>6</td><td>gulf opportunity zone industrial development revenue bonds due december 1 2028 4.55% ( 4.55 % )</td><td>21</td><td>21</td></tr><tr><td>7</td><td>less unamortized debt issuance costs</td><td>-26 ( 26 )</td><td>-27 ( 27 )</td></tr><tr><td>8</td><td>total long-term debt</td><td>1279</td><td>1278</td></tr></table> credit facility - in november 2017 , the company terminated its second amended and restated credit agreement and entered into a new credit agreement ( the \"credit facility\" ) with third-party lenders . the credit facility includes a revolving credit facility of $ 1250 million , which may be drawn upon during a period of five years from november 22 , 2017 . the revolving credit facility includes a letter of credit subfacility of $ 500 million . the revolving credit facility has a variable interest rate on outstanding borrowings based on the london interbank offered rate ( \"libor\" ) plus a spread based upon the company's credit rating , which may vary between 1.125% ( 1.125 % ) and 1.500% ( 1.500 % ) . the revolving credit facility also has a commitment fee rate on the unutilized balance based on the company 2019s leverage ratio . the commitment fee rate as of december 31 , 2017 was 0.25% ( 0.25 % ) and may vary between 0.20% ( 0.20 % ) and 0.30% ( 0.30 % ) . the credit facility contains customary affirmative and negative covenants , as well as a financial covenant based on a maximum total leverage ratio . each of the company's existing and future material wholly owned domestic subsidiaries , except those that are specifically designated as unrestricted subsidiaries , are and will be guarantors under the credit facility . in july 2015 , the company used cash on hand to repay all amounts outstanding under a prior credit facility , including $ 345 million in principal amount of outstanding term loans . as of december 31 , 2017 , $ 15 million in letters of credit were issued but undrawn , and the remaining $ 1235 million of the revolving credit facility was unutilized . the company had unamortized debt issuance costs associated with its credit facilities of $ 11 million and $ 8 million as of december 31 , 2017 and 2016 , respectively . senior notes - in december 2017 , the company issued $ 600 million aggregate principal amount of unregistered 3.483% ( 3.483 % ) senior notes with registration rights due december 2027 , the net proceeds of which were used to repurchase the company's 5.000% ( 5.000 % ) senior notes due in 2021 in connection with the 2017 redemption described below . in november 2015 , the company issued $ 600 million aggregate principal amount of unregistered 5.000% ( 5.000 % ) senior notes due november 2025 , the net proceeds of which were used to repurchase the company's 7.125% ( 7.125 % ) senior notes due in 2021 in connection with the 2015 tender offer and redemption described below . interest on the company's senior notes is payable semi-annually . the terms of the 5.000% ( 5.000 % ) and 3.483% ( 3.483 % ) senior notes limit the company 2019s ability and the ability of certain of its subsidiaries to create liens , enter into sale and leaseback transactions , sell assets , and effect consolidations or mergers . the company had unamortized debt issuance costs associated with the senior notes of $ 15 million and $ 19 million as of december 31 , 2017 and 2016 , respectively. .\nConversations: \nq0: what was the change in the unamortized debt issuance costs associated with the senior notes between 2016 and 2017? {answer0}\nq1: so what was the percentage change during this time? {answer1}\nQuestion: what was the change associated with credit facilities during that time?\nAnswer:\nGold Answer: 3.0\nModel Answer: 1250.0\nExact: False F1: 0.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: as of december 31 , 2017 , the company had gross state income tax credit carry-forwards of approximately $ 20 million , which expire from 2018 through 2020 . a deferred tax asset of approximately $ 16 million ( net of federal benefit ) has been established related to these state income tax credit carry-forwards , with a valuation allowance of $ 7 million against such deferred tax asset as of december 31 , 2017 . the company had a gross state net operating loss carry-forward of $ 39 million , which expires in 2027 . a deferred tax asset of approximately $ 3 million ( net of federal benefit ) has been established for the net operating loss carry-forward , with a full valuation allowance as of december 31 , 2017 . other state and foreign net operating loss carry-forwards are separately and cumulatively immaterial to the company 2019s deferred tax balances and expire between 2026 and 2036 . 14 . debt long-term debt consisted of the following: . <table class='wikitable'><tr><td>1</td><td>( $ in millions )</td><td>december 31 2017</td><td>december 31 2016</td></tr><tr><td>2</td><td>senior notes due december 15 2021 5.000% ( 5.000 % )</td><td>2014</td><td>600</td></tr><tr><td>3</td><td>senior notes due november 15 2025 5.000% ( 5.000 % )</td><td>600</td><td>600</td></tr><tr><td>4</td><td>senior notes due december 1 2027 3.483% ( 3.483 % )</td><td>600</td><td>2014</td></tr><tr><td>5</td><td>mississippi economic development revenue bonds due may 1 2024 7.81% ( 7.81 % )</td><td>84</td><td>84</td></tr><tr><td>6</td><td>gulf opportunity zone industrial development revenue bonds due december 1 2028 4.55% ( 4.55 % )</td><td>21</td><td>21</td></tr><tr><td>7</td><td>less unamortized debt issuance costs</td><td>-26 ( 26 )</td><td>-27 ( 27 )</td></tr><tr><td>8</td><td>total long-term debt</td><td>1279</td><td>1278</td></tr></table> credit facility - in november 2017 , the company terminated its second amended and restated credit agreement and entered into a new credit agreement ( the \"credit facility\" ) with third-party lenders . the credit facility includes a revolving credit facility of $ 1250 million , which may be drawn upon during a period of five years from november 22 , 2017 . the revolving credit facility includes a letter of credit subfacility of $ 500 million . the revolving credit facility has a variable interest rate on outstanding borrowings based on the london interbank offered rate ( \"libor\" ) plus a spread based upon the company's credit rating , which may vary between 1.125% ( 1.125 % ) and 1.500% ( 1.500 % ) . the revolving credit facility also has a commitment fee rate on the unutilized balance based on the company 2019s leverage ratio . the commitment fee rate as of december 31 , 2017 was 0.25% ( 0.25 % ) and may vary between 0.20% ( 0.20 % ) and 0.30% ( 0.30 % ) . the credit facility contains customary affirmative and negative covenants , as well as a financial covenant based on a maximum total leverage ratio . each of the company's existing and future material wholly owned domestic subsidiaries , except those that are specifically designated as unrestricted subsidiaries , are and will be guarantors under the credit facility . in july 2015 , the company used cash on hand to repay all amounts outstanding under a prior credit facility , including $ 345 million in principal amount of outstanding term loans . as of december 31 , 2017 , $ 15 million in letters of credit were issued but undrawn , and the remaining $ 1235 million of the revolving credit facility was unutilized . the company had unamortized debt issuance costs associated with its credit facilities of $ 11 million and $ 8 million as of december 31 , 2017 and 2016 , respectively . senior notes - in december 2017 , the company issued $ 600 million aggregate principal amount of unregistered 3.483% ( 3.483 % ) senior notes with registration rights due december 2027 , the net proceeds of which were used to repurchase the company's 5.000% ( 5.000 % ) senior notes due in 2021 in connection with the 2017 redemption described below . in november 2015 , the company issued $ 600 million aggregate principal amount of unregistered 5.000% ( 5.000 % ) senior notes due november 2025 , the net proceeds of which were used to repurchase the company's 7.125% ( 7.125 % ) senior notes due in 2021 in connection with the 2015 tender offer and redemption described below . interest on the company's senior notes is payable semi-annually . the terms of the 5.000% ( 5.000 % ) and 3.483% ( 3.483 % ) senior notes limit the company 2019s ability and the ability of certain of its subsidiaries to create liens , enter into sale and leaseback transactions , sell assets , and effect consolidations or mergers . the company had unamortized debt issuance costs associated with the senior notes of $ 15 million and $ 19 million as of december 31 , 2017 and 2016 , respectively. .\nConversations: \nq0: what was the change in the unamortized debt issuance costs associated with the senior notes between 2016 and 2017? {answer0}\nq1: so what was the percentage change during this time? {answer1}\nq2: what was the change associated with credit facilities during that time? {answer2}\nQuestion: so what was the percentage change?\nAnswer:\nGold Answer: 0.375\nModel Answer: 0.16667\nExact: False F1: 0.0\n\nQuestion: In the context of this series of interconnected finance-related queries and the additional information provided by the pretext, table data, and posttext from a company's financial filings, please provide a response to the final question. This may require extracting information from the context and performing mathematical calculations. Please take into account the information provided in the preceding questions and their answers when formulating your response:\nContext: notes to consolidated financial statements 2013 ( continued ) ( amounts in millions , except per share amounts ) cash flows for 2010 , we expect to contribute $ 25.2 and $ 9.2 to our foreign pension plans and domestic pension plans , respectively . a significant portion of our contributions to the foreign pension plans relate to the u.k . pension plan . additionally , we are in the process of modifying the schedule of employer contributions for the u.k . pension plan and we expect to finalize this during 2010 . as a result , we expect our contributions to our foreign pension plans to increase from current levels in 2010 and subsequent years . during 2009 , we contributed $ 31.9 to our foreign pension plans and contributions to the domestic pension plan were negligible . the following estimated future benefit payments , which reflect future service , as appropriate , are expected to be paid in the years indicated below . domestic pension plans foreign pension plans postretirement benefit plans . <table class='wikitable'><tr><td>1</td><td>years</td><td>domestic pension plans</td><td>foreign pension plans</td><td>postretirement benefit plans</td></tr><tr><td>2</td><td>2010</td><td>$ 17.2</td><td>$ 23.5</td><td>$ 5.8</td></tr><tr><td>3</td><td>2011</td><td>11.1</td><td>24.7</td><td>5.7</td></tr><tr><td>4</td><td>2012</td><td>10.8</td><td>26.4</td><td>5.7</td></tr><tr><td>5</td><td>2013</td><td>10.5</td><td>28.2</td><td>5.6</td></tr><tr><td>6</td><td>2014</td><td>10.5</td><td>32.4</td><td>5.5</td></tr><tr><td>7</td><td>2015 2013 2019</td><td>48.5</td><td>175.3</td><td>24.8</td></tr></table> the estimated future payments for our postretirement benefit plans are before any estimated federal subsidies expected to be received under the medicare prescription drug , improvement and modernization act of 2003 . federal subsidies are estimated to range from $ 0.5 in 2010 to $ 0.6 in 2014 and are estimated to be $ 2.4 for the period 2015-2019 . savings plans we sponsor defined contribution plans ( the 201csavings plans 201d ) that cover substantially all domestic employees . the savings plans permit participants to make contributions on a pre-tax and/or after-tax basis and allows participants to choose among various investment alternatives . we match a portion of participant contributions based upon their years of service . amounts expensed for the savings plans for 2009 , 2008 and 2007 were $ 35.1 , $ 29.6 and $ 31.4 , respectively . expense includes a discretionary company contribution of $ 3.8 , $ 4.0 and $ 4.9 offset by participant forfeitures of $ 2.7 , $ 7.8 , $ 6.0 in 2009 , 2008 and 2007 , respectively . in addition , we maintain defined contribution plans in various foreign countries and contributed $ 25.0 , $ 28.7 and $ 26.7 to these plans in 2009 , 2008 and 2007 , respectively . deferred compensation and benefit arrangements we have deferred compensation arrangements which ( i ) permit certain of our key officers and employees to defer a portion of their salary or incentive compensation , or ( ii ) require us to contribute an amount to the participant 2019s account . the arrangements typically provide that the participant will receive the amounts deferred plus interest upon attaining certain conditions , such as completing a certain number of years of service or upon retirement or termination . as of december 31 , 2009 and 2008 , the deferred compensation liability balance was $ 100.3 and $ 107.6 , respectively . amounts expensed for deferred compensation arrangements in 2009 , 2008 and 2007 were $ 11.6 , $ 5.7 and $ 11.9 , respectively . we have deferred benefit arrangements with certain key officers and employees that provide participants with an annual payment , payable when the participant attains a certain age and after the participant 2019s employment has terminated . the deferred benefit liability was $ 178.2 and $ 182.1 as of december 31 , 2009 and 2008 , respectively . amounts expensed for deferred benefit arrangements in 2009 , 2008 and 2007 were $ 12.0 , $ 14.9 and $ 15.5 , respectively . we have purchased life insurance policies on participants 2019 lives to assist in the funding of the related deferred compensation and deferred benefit liabilities . as of december 31 , 2009 and 2008 , the cash surrender value of these policies was $ 119.4 and $ 100.2 , respectively . in addition to the life insurance policies , certain investments are held for the purpose of paying the deferred compensation and deferred benefit liabilities . these investments , along with the life insurance policies , are held in a separate revocable trust for the purpose of paying the deferred compensation and the deferred benefit .\nConversations: \nQuestion: what is the ratio of discretionary company contributions to total expensed amounts for savings plans in 2009?\nAnswer:\nGold Answer: 0.10826\nModel Answer: 0.12245\nExact: False F1: 0.0\n",
          "output_type": "stream"
        },
        {
          "name": "stderr",
          "text": "\n",
          "output_type": "stream"
        }
      ],
      "execution_count": null
    }
  ]
}